All Pharma articles – Page 12
-
NewsNHS England moves to clear up flu vaccine confusion
NHS England has moved to try to clear up confusion over flu vaccines for next winter, following concerns that a better approach last year could have reduced pressure in hospitals.
-
NewsTrust expects to miss control total deficit by £30m
A south eastern trust is predicting a deficit worth over £56m – more than double its original plan and 15 per cent of its total income – after being hit by lower elective income and losing a payments dispute with local commissioners.
-
CommentPrivate investment can transform primary care estate
Private finance as an option to fund an upgrade of primary care estate can deliver value for money for the taxpayer and significantly improve patient outcomes, writes Maisie Borrows
-
HSJ LocalExclusive: CCGs across region refuse to commission flu antivirals
Clinical leaders across three sustainability and transformation partnerships are defying public health guidelines and refusing to commission flu antivirals, HSJ can reveal.
-
NewsExclusive: NHS England vaccine advice 'increased risk of flu admissions'
More patients may have been admitted to hospital with flu this winter after NHS England asked GPs to order a less expensive flu vaccine, a senior doctor has warned.
-
CommentTaking a cue about utilising data to enhance healthcare
The Australians may have big ambitions, but we can match them, as long as we don’t over play the role of big data. By Marc Farr
-
NewsCCGs facing 'significant financial risk' after generic drug price surge
Clinical commissioning groups are facing “significant financial risk” this financial year due to supply issues pushing up the prices they have to pay for generic drugs.
-
News'Real risk of deaths' without national level e-prescribing changes
A national electronic prescribing system used in the treatment of millions of people needs to make changes to prevent patient deaths, a coroner has said.
-
NewsHigh Court rejects pharma industry's challenge to drug cost controls
The High Court has thrown out a legal challenge by the drugs industry to a controversial affordability test on the introduction of new treatments.
-
NewsNine trusts plan pharma network to save £17m
Nine acute trusts are collaborating on a pharmaceutical network that could achieve efficiency savings estimated at more than £17m.
-
NewsNMC: All graduate nurses should be ready to prescribe
Nurses could be able to prescribe medication “much sooner” in their careers than they currently can under plans being consulted on by the Nursing and Midwifery Council.
-
NewsCCG and ICO probe pharmacy firm's access to patient details
A clinical commissioning group and the Information Commissioner are looking into concerns raised by a patient that a major online pharmacy has gained access to patients’ details to send out marketing material.
-
NewsNHS England 'unethical' to propose withdrawing life changing drug
NHS England has been accused of being “totally unethical” after proposing to stop paying for a thyroid drug that is the “difference between living properly and not doing so” for patients.
-
News'Dysfunctional' NHS England project damages UK reputation, say health tech firms
An organisation representing health technology firms has claimed a “dysfunctional” NHS England project is denying patients access to “life changing” treatment.
-
News
NHS England 'no option' but to hold back £120m from CCGs
“Urgent steps” have been taken to hold back funding intended for clinical commissioning groups, to help the Department of Health deliver financial balance this year.
-
NewsNHS England defeated in court again over 'life changing' drug
A High Court judge has rebuked NHS England for denying a life changing drug to a seven year old boy in the face of “overwhelming” clinical evidence.
-
NewsPharma manager named as new DH chief commercial officer
The Department of Health has appointed a new chief commercial officer who will lead the renegotiation of pharmaceutical pricing regulation scheme.
-
CommentThe NHS is failing to keep up with the science
The NHS will be unable to provide new and advanced treatments unless policy makers take steps to mend its long term financial position, warns Harry Quilter-Pinner
-
NewsPrescription changes would worsen health inequalities, warns BMA
The chair of the British Medical Association’s prescribing subcommittee has called for politicians to lead on changes to NHS prescriptions, which he claims could worsen health inequalities.
-
NewsNHS England names 'ineffective' medicines for savings drive
NHS England is to consult over limiting the prescription of “low value” products costing £141m a year including homeopathy and herbal medicines.